日水製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証PRM | 医薬品 | 4550/E00971 | Nissui Pharmaceutical Co., Ltd |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|---|---|---|---|---|---|---|---|---|
2014/07/04 | 日証協 | 10,100株 | -24.06% | 600株 | -86.67% | 86,033株 | -4.34% | 600株 | -64.89% |
2014/06/27 | 日証協 | 13,300株 | +31.68% | 4,500株 | +104.55% | 89,933株 | -8.28% | 1,709株 | -83.25% |
2014/06/20 | 日証協 | 10,100株 | -33.11% | 2,200株 | +633.33% | 98,054株 | -4.11% | 10,200株 | +750% |
2014/06/13 | 日証協 | 15,100株 | -39.6% | 300株 | -50% | 102,254株 | -4.13% | 1,200株 | -77.36% |
2014/06/06 | 日証協 | 25,000株 | -22.6% | 600株 | -50% | 106,654株 | -8.34% | 5,300株 | +488.89% |
2014/05/30 | 日証協 | 32,300株 | -26.09% | 1,200株 | -67.56% | 116,362株 | -5.06% | 900株 | -85% |
2014/05/23 | 日証協 | 43,700株 | -1.36% | 3,699株 | +208.25% | 122,563株 | -0.24% | 6,001株 | +150.04% |
2014/05/16 | 日証協 | 44,301株 | -12.1% | 1,200株 | -20% | 122,862株 | -4.58% | 2,400株 | +41.18% |
2014/05/09 | 日証協 | 50,401株 | -9.19% | 1,500株 | +200% | 128,762株 | -1.45% | 1,700株 | +9999.99% |
2014/05/02 | 日証協 | 55,501株 | -5.45% | 500株 | 0% | 130,662株 | -2.23% | 10株 | -99.53% |
2014/04/25 | 日証協 | 58,701株 | -13.17% | 500株 | -80.77% | 133,642株 | -6.77% | 2,110株 | -52.05% |
2014/04/18 | 日証協 | 67,601株 | +5.13% | 2,600株 | -98.15% | 143,342株 | +4.52% | 4,400株 | +18.25% |
2014/04/11 | 日証協 | 64,301株 | +6.81% | 140,200株 | +4148.48% | 137,141株 | +2.33% | 3,721株 | -89.93% |
2014/04/04 | 日証協 | 60,202株 | -8.51% | 3,300株 | -38.89% | 134,012株 | +3.2% | 36,960株 | -8.35% |
2014/03/28 | 日証協 | 65,802株 | -38.56% | 5,400株 | -50% | 129,862株 | -26.14% | 40,328株 | +310.67% |
2014/03/20 | 日証協 | 107,102株 | -1.11% | 10,800株 | -62.11% | 175,811株 | -2.04% | 9,820株 | -63.52% |
2014/03/14 | 日証協 | 108,302株 | +21.14% | 28,500株 | -13.11% | 179,471株 | +11.15% | 26,920株 | +16.54% |
2014/03/07 | 日証協 | 89,402株 | +9.29% | 32,801株 | -14.13% | 161,471株 | +8.82% | 23,100株 | -36.9% |
2014/02/28 | 日証協 | 81,802株 | +31.09% | 38,200株 | +93.91% | 148,384株 | +13.2% | 36,608株 | +46.97% |
※株式分割は考慮していませんのでご注意ください。